NLRP3 and type 2 diabetes mellitus: In addition, previous research reported that Tan I reduced insulin resistance in type 2 diabetes rats (Wei et al. 2017) as well as osteoarthritis in mice (Wang et al. 2019a), NLRP3 inflammasome activation also act as a key role in the progression of type 2 diabetes as well as osteoarthritis.